Market Research - N/A, N/A, US
CureGrail's technology and collaborative partnerships enables computer-based experimentation of human body systems and processes in health and disease. This approach enables pharmaceutical companies to use simulation to identify novel treatment approaches and targets, saving valuable time and resources. The company's initial area of focus is exploring cures for diabetes, a chronic, progressive disease characterized by elevated levels of blood glucose. More than 400 million adults live with diabetes globally, and the global antidiabetics market exceeds $5 billion.
Outlook
Typekit
Mobile Friendly